Form 483

Mylan Laboratories Limited Form 483, 2019-05-13

FDA issued a Form 483 to Mylan Laboratories Limited on 2019-05-13 with 12 public-safe observations.

483· Form 483 issuedHuman Drugs12 observations

Mylan Laboratories Limited · Bangalore, India · Issued May 13, 2019

Overview

  • 12 public-safe observations are available for this inspection.
  • 11 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

13 May 2019
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Dipesh K Shah, Thomas J Arista

13 May 2019
21 CFR 211.63

Equipment Design, Size and Location

Cited by Dipesh K Shah, Thomas J Arista

13 May 2019
21 CFR 211.65(a)

Equipment construction - reactive surfaces

Cited by Dipesh K Shah, Thomas J Arista

13 May 2019
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Dipesh K Shah, Thomas J Arista

13 May 2019
21 CFR 211.68(b)

Backup data not assured as exact and complete

Cited by Dipesh K Shah, Thomas J Arista

Inspected site

MLMylan Laboratories LimitedBangalore, India

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations2x
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.42(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(9)Cited across public-safe Form 483 observations1x
21 CFR 211.46(b)Cited across public-safe Form 483 observations1x
21 CFR 211.46(c)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.65(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 12 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere